Ophir Eran 4

What Happened
Ophir Eran, President & CEO and a director of Compugen Ltd (CGEN), exercised 5,625 stock options and acquired 5,625 shares at a strike price of $0.83 (total cost $4,664) on April 1, 2026. The same day he sold those 5,625 shares in the open market for a weighted-average price of $2.21, generating proceeds of $12,413. The transactions were reported as option exercise (code M) and an open-market sale (code S).

Key Details

• Transaction date: 2026-04-01; Form 4 filed 2026-04-03 (timely filing).
• Exercise: 5,625 shares acquired at $0.83 per share (total $4,664).
• Sale: 5,625 shares sold at a weighted-average $2.21 per share (total $12,413); sale prices ranged $2.20–$2.225. (Reporting person will provide breakdown on request.)
• Additional derivative entry: a corresponding M-code disposal at $0.00 reflects the option conversion/disposition reported in the filing.
• Footnotes: F1 — transaction executed under a Rule 10b5‑1 trading plan adopted Dec 26, 2025; F3 — the option had a vesting schedule (25% vested Dec 31, 2023, remainder in equal quarterly installments).
• Shares owned after the transaction are not specified in the supplied summary of the filing.

Context

• This was an exercise of options immediately followed by an open‑market sale the same day — effectively converting vested options into cash. Such same‑day exercise-and-sell activity is commonly done for liquidity or tax purposes and was executed under a pre-established 10b5‑1 plan.
• The dollar amounts are modest (roughly $12.4k in gross sale proceeds); the sale does not by itself indicate broader insider sentiment.